| Bioactivity | (±)-Iroxanadine (BRX 005; BRX 235), a vasculoprotector, is a p38 kinase and HSP protein activator. (±)-Iroxanadine has the potential for atherosclerosis and vascular diseases research[1]. |
| Invitro | (±)-Iroxanadine（BRX 235；0.1 µM；14-24 小时）在血管内皮细胞中具有细胞保护特性[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> (±)-Iroxanadine 相关抗体: Cell Viability Assay[1] Cell Line: |
| CAS | 203805-20-3 |
| Formula | C14H20N4O |
| Molar Mass | 260.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. A E Kabakov, et al. Pharmacological attenuation of apoptosis in reoxygenated endothelial cells. Cell Mol Life Sci. 2004 Dec;61(24):3076-86. |
(±)-Iroxanadine
CAS: 203805-20-3 F: C14H20N4O W: 260.33
(±)-Iroxanadine (BRX 005; BRX 235), a vasculoprotector, is a p38 kinase and HSP protein activator. (±)-Iroxanadine has
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.